Return to search results
Erythromycin
Erythromycin is a prescription antibiotic from the macrolide class, used to treat bacterial infections and sometimes acne. Available as delayed-release oral tablets in 250 mg, 333 mg, and 500 mg strengths, it's manufactured by Amneal Pharmaceuticals NY LLC. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Erythromycin is a prescription antibiotic from the macrolide class, used to treat bacterial infections and sometimes acne. Available as delayed-release oral tablets in 250 mg, 333 mg, and 500 mg strengths, it's manufactured by Amneal Pharmaceuticals NY LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Erythromycin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Erythromycin — ANDA 061904 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=061904"
}
]
|
| identifier | ANDA061904 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Erythromycin |
